Shenzhen YHLO Biotech Co., Ltd. — Investor Relations & Filings
Shenzhen YHLO Biotech Co., Ltd. specializes in the research, development, and manufacturing of advanced diagnostic solutions, with a primary focus on chemiluminescence immunoassay (CLIA) technology. The company provides a comprehensive range of automated laboratory instruments, including the iFlash series and UNICELL integrated systems, alongside an extensive menu of reagents. Its clinical applications span diverse fields such as autoimmunity, reproductive health, infectious diseases, diabetes, and cardiac markers. By integrating innovative engineering with clinical chemistry, the company delivers high-throughput, sensitive diagnostic tools designed to optimize laboratory workflows and enhance clinical decision-making. Its products serve a global network of hospitals and medical laboratories, emphasizing precision and reliability in patient testing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年年度股东会会议资料 | 2026-05-13 | Chinese | |
| 董事、高级管理人员薪酬管理制度（2026年4月） | 2026-04-28 | Chinese | |
| 2025年度募集资金存放、管理与使用情况专项报告的鉴证报告 | 2026-04-28 | Chinese | |
| 2025年内部控制评价报告 | 2026-04-28 | Chinese | |
| 2026年第一季度报告 | 2026-04-28 | Chinese | |
| 关于召开2025年年度股东会的通知 | 2026-04-28 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45773932 | 2025年年度股东会会议资料 | 2026-05-13 | Chinese | ||
| 44475457 | 董事、高级管理人员薪酬管理制度（2026年4月） | 2026-04-28 | Chinese | ||
| 44475450 | 2025年度募集资金存放、管理与使用情况专项报告的鉴证报告 | 2026-04-28 | Chinese | ||
| 44475418 | 2025年内部控制评价报告 | 2026-04-28 | Chinese | ||
| 44475411 | 2026年第一季度报告 | 2026-04-28 | Chinese | ||
| 44475407 | 关于召开2025年年度股东会的通知 | 2026-04-28 | Chinese | ||
| 44475405 | 信息披露管理制度（2026年4月） | 2026-04-28 | Chinese | ||
| 44475390 | 2025年度内部控制审计报告 | 2026-04-28 | Chinese | ||
| 44475374 | 董事会关于独立董事独立性情况的专项意见 | 2026-04-28 | Chinese | ||
| 44475357 | 关于2026年度对外担保额度预计的公告 | 2026-04-28 | Chinese | ||
| 44475345 | 对外投资管理办法（2026年4月） | 2026-04-28 | Chinese | ||
| 44475343 | 关于公司2025年度利润分配方案公告 | 2026-04-28 | Chinese | ||
| 44475337 | 北京市君合（深圳）律师事务所关于深圳市亚辉龙生物科技股份有限公司2026年第一次临时股东会的法律意见书 | 2026-04-27 | Chinese | ||
| 44475326 | 2026年第一次临时股东会决议公告 | 2026-04-27 | Chinese | ||
| 44475322 | 2026年第一次临时股东会会议资料 | 2026-04-16 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shenzhen YHLO Biotech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58500/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58500 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58500 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58500 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58500}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shenzhen YHLO Biotech Co., Ltd. (id: 58500)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.